Assessing The Best Biotech ETFs
While the biotech sector has outperformed the broader market over the past 12 months, investing in this sector can be risky. As such, the author… Read More »Assessing The Best Biotech ETFs
While the biotech sector has outperformed the broader market over the past 12 months, investing in this sector can be risky. As such, the author… Read More »Assessing The Best Biotech ETFs
Today’s article details two stocks that, according to both analysts at JPMorgan as well as the broader Wall Street analyst consensus, are primed for strong… Read More »2 Stocks Where Analysts See Strong Gains Ahead
It appears that a mystery investor has recently spent more than $300 million buying up tens of thousands of S&P 500 call spreads that expire… Read More »A Mystery Investor’s Massive Post-Election Bet
The group of stocks that are the focus of today’s article have been experiencing an incredible run-up this year, with their outperformance likely attributable to… Read More »These Biden-Boosted Stocks Could Continue To Be Winners Even If He Loses
Companies involved in biopharmaceuticals, medical devices and biotechnology medicines make up the nine new biotech stocks to watch highlighted in today’s article, which also highlights… Read More »New Biotech Stocks To Watch – And More!
A deluge of data for various COVID-19 vaccine candidates is expected in the next month or two, and today’s article notes that strategists at Goldman… Read More »Bracing For COVID Vaccine Results — Encouraging Or Disappointing — In The Coming Weeks
“Smart investors will look for biotech stocks that have drug pipelines full of good prospects, as well as balance sheets strong enough to withstand any… Read More »Strong Drug Pipelines (And Balance Sheets) May Make These The Best Biotech Stocks To Buy Right Now
“This year didn’t start out with a bang for these two biotechs, but their performances over the past few months have been breathtaking,” observes the… Read More »Having Posted Tremendous Gains In Recent Months, Are Either Of These 2 Small-Cap Biotech Stocks Buys?
When it comes to the question of which biotech companies could be the next M&A targets, one analyst cited in today’s article says the “easy… Read More »The Next Biotechs To Be Bought Up
Investors looking for a post-election idea may want to consider the ETF highlighted in today’s article, which tracks an index “comprised of small- and mid-cap… Read More »Market History Suggests This “Breakthrough” ETF Is A Smart Post-Election Idea